drgunasakaran1 ★★ ![]() 2013-10-24 17:43 (4220 d 02:31 ago) @ Clarc Posting: # 11751 Views: 4,852 |
|
Dear Clarc, ❝ Can I define in the protocol a widening to 0.75-1.33, or I have to perform a reference scaled bioequivalence? For EU submission, it is suggested to go for Expandable BE limits as per EMA's Guideline on the Investigation of Bioequivalence — Dr Gunasakaran Sambandan MD Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn |
Helmut ★★★ ![]() ![]() Vienna, Austria, 2013-10-25 16:56 (4219 d 03:18 ago) @ Clarc Posting: # 11768 Views: 4,761 |
|
Hi Clarc, ❝ Our statistical software doesn't permit scaling, only widening to 0.75-1.33. The design is a fully replicated TRTR/RTRT design. May I guess: Kinetica? If yes, AFAIK you cannot evaluate replicate designs at all. ❝ Can I define in the protocol a widening to 0.75-1.33, You could, but it will not be accepted… ❝ or I have to perform a reference scaled bioequivalence? Yes – see Dr. Gunasakaran’s post above. Don’t forget two obstacles:
— Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![]() Helmut Schütz ![]() The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |